Key Market Indicators
Sales of antidepressant medications in Germany are projected to climb to approximately $990 million by 2028, up from nearly $890 million in 2023. This represents an annual growth rate of 1.8%. Since 1991, the German market for these medications has experienced a modest average annual growth of 1%. Globally, Spain, Italy, and Australia hold the second, third, and fourth positions, respectively, in terms of antidepressant sales.
